BOSTON – At a press conference at the BIO International Conference, Alxerion Biotech Inc., a new Massachusetts Institute of Technology (MIT) biotech startup, discussed how it is developing new technologies to harness the therapeutic potential of exosomes, small lipid bilayer vesicles, which are part of the transportable cell secretome.